Moreover, a characterization of LGALS3BP glycosylation pattern could be useful to discriminate whether the vesicular forms isolated from cancer patients may differ from that obtained from healthy samples, thus increasing the specificity of LGALS3BP as a GBM associated marker. Here, LGALS3BP is linked to glioblastoma.